Achieving Viral Suppression in 90% of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities

Jean B. Nachega, Nadia A. Sam-Agudu, Lynne M. Mofenson, Mauro Schechter, John W. Mellors

Research output: Contribution to journalReview articlepeer-review

40 Scopus citations

Abstract

Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third "90%" (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and €'supported, cost-effective, and tailored to a wide range of global communities.

Original languageEnglish (US)
Pages (from-to)1487-1491
Number of pages5
JournalClinical Infectious Diseases
Volume66
Issue number10
DOIs
StatePublished - May 2 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s) 2018.

Keywords

  • 90-90-90
  • antiretroviral therapy (ARV)
  • human immunodeficiency virus (HIV)
  • low- and middle-income countries (LMICs)
  • viral suppression

Fingerprint

Dive into the research topics of 'Achieving Viral Suppression in 90% of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities'. Together they form a unique fingerprint.

Cite this